257 related articles for article (PubMed ID: 35864548)
21. Identification of necroptosis-related gene signature and characterization of tumour microenvironment infiltration in non-small-cell lung cancer.
Dai J; Fu Y
J Cell Mol Med; 2022 Sep; 26(17):4698-4709. PubMed ID: 35871768
[TBL] [Abstract][Full Text] [Related]
22. Identification and Quantification of Necroptosis Landscape on Therapy and Prognosis in Kidney Renal Clear Cell Carcinoma.
Xin S; Mao J; Duan C; Wang J; Lu Y; Yang J; Hu J; Liu X; Guan W; Wang T; Wang S; Liu J; Song W; Song X
Front Genet; 2022; 13():832046. PubMed ID: 35237304
[TBL] [Abstract][Full Text] [Related]
23. Identification and Verification of Necroptosis-Related Gene Signature With Prognosis and Tumor Immune Microenvironment in Ovarian Cancer.
Wang Z; Chen G; Dai F; Liu S; Hu W; Cheng Y
Front Immunol; 2022; 13():894718. PubMed ID: 35812403
[TBL] [Abstract][Full Text] [Related]
24. Identification and validation of necroptosis-related gene signatures to predict clinical outcomes and therapeutic responses in acute myeloid leukemia.
Wen XM; Xu ZJ; Ma JC; Xia PH; Jin Y; Chen XY; Qian W; Lin J; Qian J
Aging (Albany NY); 2023 Nov; 15(24):14677-14702. PubMed ID: 37993258
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Model Associated with Necroptosis in Colorectal Cancer based on Transcriptomic Analysis and Experimental Validation.
Huang Y; Li L; Kang Z; Luo H; Lin X; Zhao S; Zhang Q; Li Q; Liu H; Li M
Front Biosci (Landmark Ed); 2024 Mar; 29(3):98. PubMed ID: 38538261
[TBL] [Abstract][Full Text] [Related]
26. Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.
Ma Y; Du J; Chen M; Gao N; Wang S; Mi Z; Wei X; Zhao J
Front Immunol; 2023; 14():1219652. PubMed ID: 37457713
[TBL] [Abstract][Full Text] [Related]
27. Ferroptosis regulators, especially SQLE, play an important role in prognosis, progression and immune environment of breast cancer.
Tang W; Xu F; Zhao M; Zhang S
BMC Cancer; 2021 Oct; 21(1):1160. PubMed ID: 34715817
[TBL] [Abstract][Full Text] [Related]
28. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer.
Shi H; Peng Q; Zhou X; He Y; Sun S
Front Genet; 2022; 13():848747. PubMed ID: 35419022
[TBL] [Abstract][Full Text] [Related]
29. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
Front Immunol; 2022; 13():964118. PubMed ID: 36059470
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic and therapeutic target biomarker based on necroptosis-related gene signature and immune microenvironment infiltration in gastric cancer.
Xin D; Man Y; Yang Y; Wang F
Front Genet; 2022; 13():953997. PubMed ID: 36092932
[No Abstract] [Full Text] [Related]
31. Development and validation of a necroptosis-related gene prognostic score to predict prognosis and efficiency of immunotherapy in gastric cancer.
Xia Y; Zhang R; Wang M; Li J; Dong J; He K; Guo T; Ju X; Ru J; Zhang S; Sun Y
Front Immunol; 2022; 13():977338. PubMed ID: 36159818
[TBL] [Abstract][Full Text] [Related]
32. A Novel Necroptosis-Related Signature Can Predict Prognosis and Chemotherapy Sensitivity in Multiple Myeloma.
Jiang JY; Yao FY; Liu J; Wang XL; Huang B; Zhong FM; Wang XZ
Technol Cancer Res Treat; 2024; 23():15330338241232554. PubMed ID: 38361483
[TBL] [Abstract][Full Text] [Related]
33. A necroptosis gene signature predicts prostate cancer recurrence, and is linked to somatic mutation, therapeutic landscape, and immune infiltration.
Wang Y; Zhang X; Wu L; Feng Q; Luo Z; Zeng T; Luo J
Am J Transl Res; 2023; 15(4):2460-2480. PubMed ID: 37193176
[TBL] [Abstract][Full Text] [Related]
34. Immune infiltration and a necroptosis-related gene signature for predicting the prognosis of patients with cervical cancer.
Xing X; Tian Y; Jin X
Front Genet; 2022; 13():1061107. PubMed ID: 36685937
[No Abstract] [Full Text] [Related]
35. Identification of a Necroptosis-Related Prognostic Signature and Associated Regulatory Axis in Liver Hepatocellular Carcinoma.
He A; Huang Z; Wang J; Lu H; Zhang R; Wu L; Feng Q
Dis Markers; 2022; 2022():3968303. PubMed ID: 35855852
[TBL] [Abstract][Full Text] [Related]
36. Identification of CD4
Ning S; Wu J; Pan Y; Qiao K; Li L; Huang Q
Front Immunol; 2022; 13():880769. PubMed ID: 35603183
[TBL] [Abstract][Full Text] [Related]
37. Landscape of prognosis and immunotherapy responsiveness under tumor glycosylation-related lncRNA patterns in breast cancer.
Lv W; Tan Y; Zhou X; Zhang Q; Zhang J; Wu Y
Front Immunol; 2022; 13():989928. PubMed ID: 36189319
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma.
Zhang J; He X; Hu J; Li T
Front Genet; 2022; 13():920350. PubMed ID: 35754848
[TBL] [Abstract][Full Text] [Related]
39. Necroptosis-Related Modification Patterns Depict the Tumor Microenvironment, Redox Stress Landscape, and Prognosis of Ovarian Cancer.
Geng R; Zhong Z; Ni S; Liu W; He Z; Gan S; Huang Q; Yu H; Bai J; Liu J
Oxid Med Cell Longev; 2023; 2023():4945288. PubMed ID: 37082103
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive Profiling Reveals Prognostic and Immunogenic Characteristics of Necroptosis in Soft Tissue Sarcomas.
Qi L; Xu R; Ren X; Zhang W; Yang Z; Tu C; Li Z
Front Immunol; 2022; 13():877815. PubMed ID: 35663937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
